Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis

Abroad (travel likely)RecruitingPHASE4

Conditions

Takayasu Arteritis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Lindi Jiang, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Lindi Jiang, Ph.D) · zsh-rheum@hotmail.com · 86-02164041990

Study leads

Lindi Jiang, Ph.D., M.D.
Study Chair
Department of Rheumatology in Zhongshan hospital, Fudan University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis

Takayasu Arteritis

Abroad (travel likely)RecruitingPHASE4

Shanghai, China

Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases

Rheumatoid Arthritis (RA) · Juvenile Idiopathic Arthritis (JIA) · Systemic Lupus Erythematosus (SLE)

Abroad (travel likely)RecruitingPHASE4

São Paulo, Brazil · São Paulo, Brazil

A Pilot Study in Severe Patients With Takayasu Arteritis.

Takayasu Arteritis · Tocilizumab · Adalimumab

Abroad (travel likely)RecruitingPHASE4

Shanghai, China

EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases

Myocarditis · ANCA Associated Vasculitis · Pericarditis

Abroad (travel likely)Recruiting

Paris, France